Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

about

Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.WNT signalling: mechanisms and therapeutic opportunities.Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway.

P2860

Q39432317-2CC30E73-0EAE-4A26-BBD2-1FCC5B41ABF9 Q49866082-1E2EC924-1653-4E7F-9915-68F7DB6D5E76 Q55001642-18C43F93-B4D9-4C29-8C07-9E5211026BED

P2860

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Item

http://www.wikidata.org/entity/Q39345895

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

@en

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

@nl

type

Item

label

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

@en

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

@nl

prefLabel

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

@en

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

@nl

P1476

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology

@en

P2093

Xi He

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling

Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow

Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6

Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway

FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development

Wnt/beta-catenin signaling: components, mechanisms, and diseases

Wnt5a Signaling in Cancer

Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?

Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer

WNT-5A: signaling and functions in health and disease

P304

4637-4650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.13894

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

Michael H Kagey

P5008

ScienceSource

P577

2017-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28574171

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

peptide

P932

5727329

http://www.w3.org/2001/XMLSchema#string

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

about

P2860

P2860

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P50

P5008

P577

P698

P921

P932